DataTreeTM multi-segment forecasts

DataTree is Inpharmation’s expertly designed forecast scaling solution for multi-segment forecasts. Scaling up forecast models is a major challenge for the pharma industry. “Generic” forecasting templates may solve the scaling up issue – but they cannot capture the all-important, unique dynamics in a specific market.

The best forecast models have been carefully crafted to fit the shape of a specific market. Inpharmation’s FlexiCastTM platform has 73 models which can be used to flexibly answer your specific therapy area forecast requirements:

A modular approach reduces forecast errors; most new forecasts contain errors. In fact studies show that 94% of spreadsheet models contain serious errors, when not scaled using Inpharmation’s forecast scaling software, DataTree.

Inpharmation’s phRISK HyperCubeTM for DataTree allows you to run Monte-Carlo simulations where traditional approaches fail.

**Errors found in audit of 88 non-modular spreadsheet models.

%

Errors found in audit of 88 non-modular spreadsheet models.**

Many of the global top-50 pharma companies have already realized that DataTree is the next logical step in multi-segment pharma forecasts…

DataTree is the next logical step: DataTree allows you to take a single spreadsheet and automatically scale it up into a multi-country, multi-therapy area, multi-patient segment, multi-indication model.

That minimizes the chance of errors: DataTree applies battle-tested technology to the scaling-up of forecast models and eliminates the quality nightmare.

And provides a host of additional features: DataTree also provides a host of additional functionality that lies far beyond the power of conventional Excel workbooks. This includes simplifying the way forecasts are shared, consolidated and analyzed.

"I'm happy to report that my forecasting work (using Inpharmation's model) has been called out as an example of best practices." I've been asked to present the model to some of the highest ranking officers at my company."

The reason more than 70% of the top-20 global pharma companies use Inpharmation’s evidence-based forecasting platform, is because when you need accurate, reliable forecasts; you need solutions that are based upon validated, Pharma-Specific models and tools.

Most importantly, bespoke forecasting models for the pharmaceutical industry to be specific to your strategic business questions:

DataTreeTM meets your requirements for forecasting multiple therapy areas and countries in a single forecast interface.

The evidence behind Inpharmation’s fact-based approach to pricing is meticulously documented in the book Sales Forecasting for Pharmaceuticals: An Evidence-Based Approach by Inpharmation’s Managing Director, Gary Johnson.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Thank you!

Thanks! We have received your request and your information will be with you shortly.